PRESIDENT AND CEO, BIOMARKER STRATEGIES, LLC
Rockville, Maryland, United States
Jerry Parrott joined BioMarker Strategies in October 2013 as President, CEO and a Director. He previously served Human Genome Sciences, Inc. (HGSI) as Vice President, Corporate Affairs from 2001 until its acquisition by GlaxoSmithKline in late 2012. He formerly held senior positions with Bristol-Myers Squibb Company, American Hospital Supply Corporation and Walgreen Company. As Principal of his own consultancy, Jerry’s clients included HGSI, American Type Culture Collection, Bristol-Myers Squibb, Ciba-Geigy, Diversa, Exogen, Genentech, HealthCare Ventures, Hoffmann-La Roche, Rock Hill Ventures, Wyeth and others. During this period, he helped take public 3-Dimensional Pharmaceuticals, subsequently acquired by Johnson & Johnson, and InforMax, subsequently acquired by Invitrogen. Jerry serves as Chairman of Maryland Healthcare Product Development Corporation, a small nonprofit venture fund, and as a Director of Maryland Technology Council.